FDA issued a Warning Letter to Lonza Biologics, Inc. on 9/1/2011 for a later inspection.
483 Lonza Biologics Mar 2006

483 Lonza Biologics Mar 2006

Megan Haggerty FDA, Mihaly Ligmond FDA$119.00 - Available Now

FDA investigators audited the Lonza Biologics - Hopkinton, MA, United States facility and issued inspectional observations (via FDA 483) on 24 Mar 2006.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Mar 2006
  • Location: Hopkinton, United States
  • FEI: 3001701602
Add To Cart